Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIOR | US
0.04
6.61%
Healthcare
Biotechnology
30/06/2024
16/10/2024
0.59
0.56
0.60
0.55
Biora Therapeutics Inc. a biotechnology company engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity Inc. and changed its name to Biora Therapeutics Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics Inc. was founded in 2010 and is headquartered in San Diego California.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
93.9%1 month
78.3%3 months
66.9%6 months
80.7%-
-
-
-0.53
2.57
-2.03
71.81
-
-67.51M
21.52M
21.52M
-
-4.96K
-
15.80K
-
10.14
12.36
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.13
Range1M
0.21
Range3M
0.32
Rel. volume
1.04
Price X volume
159.97K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
BioXcel Therapeutics Inc | BTAI | Biotechnology | 0.58 | 23.63M | 1.95% | n/a | -139.46% |
PolyPid Ltd | PYPD | Biotechnology | 3.43 | 23.60M | 0.88% | n/a | 689.01% |
Aligos Therapeutics Inc | ALGS | Biotechnology | 7.38 | 23.59M | 1.51% | n/a | 14.63% |
Iterum Therapeutics plc | ITRM | Biotechnology | 1.03 | 23.38M | 0.98% | n/a | -198.11% |
ImmunoCellular Therapeutics Ltd | IMUC | Biotechnology | 0.138 | 23.09M | 17.95% | 0.02 | -82.78% |
HCW Biologics Inc. Common Stock | HCWB | Biotechnology | 0.6 | 22.69M | 3.45% | n/a | -159.13% |
Cyclo Therapeutics Inc | CYTH | Biotechnology | 0.79 | 22.67M | 5.33% | n/a | -58.50% |
Cocrystal Pharma Inc | COCP | Biotechnology | 2.2 | 22.38M | 20.05% | n/a | 10.24% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.159 | 22.26M | 12.77% | n/a | 21.99% |
Pieris Pharmaceuticals Inc | PIRS | Biotechnology | 16.49 | 21.51M | 1.48% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.5 | 19.04M | 4.17% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.02 | 18.42M | 2.01% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6542 | 9.49M | -5.19% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2051 | 3.68M | -6.82% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.09 | 2.84M | -0.91% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -0.99% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.42 | 0 | 2.63% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.21 | 0 | 3.19% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5 | 0 | 1.42% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.05 | 0 | 6.06% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.03 | 0.53 | Cheaper |
Ent. to Revenue | 71.81 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | - | 15.30 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 66.95 | 72.92 | Par |
Debt to Equity | -0.53 | -1.24 | Expensive |
Debt to Assets | 2.57 | 0.25 | Expensive |
Market Cap | 21.52M | 3.78B | Emerging |